Fanelli C, Fernandes BH, Machado FG, Okabe C, Malheiros DM, Fujihara CK, Zatz R. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation. Am J Physiol Renal Physiol 301: F580 -F587, 2011. First published June 8, 2011 doi:10.1152/ajprenal.00042.2011We recently standardized a model (L Lact) of severe chronic kidney disease based on impaired nephrogenesis by suppression of angiotensin II activity during lactation (Machado FG, Poppi EP, Fanelli C, Malheiros DM, Zatz R, Fujihara CK. Am J Physiol Renal Physiol 294: F1345-F1353, 2008. In this new study of the L Lact model, we sought to gain further insight into renal injury mechanisms associated with this model and to verify whether the renoprotection obtained with the association of the angiotensin II receptor blocker losartan (L) and hydrochlorothiazide (H), which arrested renal injury in the remnant kidney model, would provide similar renoprotection. Twenty Munich-Wistar dams, each nursing six pups, were divided into control, untreated, and L Lact groups, given losartan (L; 250 mg·kg Ϫ1 ·day Ϫ1 ) until weaning. The male L Lact offspring remained untreated until 7 mo of age, when renal functional and structural parameters were studied in 17 of them, used as pretreatment control (L LactPre), and followed no further. The remaining rats were then divided among groups L LactϩV, untreated; L LactϩL, given L (50 mg·kg Ϫ1 ·day Ϫ1 ) now as a therapy; LLactϩH, given H (6 mg·kg Ϫ1 ·day Ϫ1 ); and LLactϩLH, given L and H. All parameters were reassessed 3 mo later in these groups and in agematched controls. At this time, L Lact rats exhibited hypertension, severe albuminuria, glomerular damage, marked interstitial expansion/inflammation, enhanced cell proliferation, myofibroblast infiltration, and creatinine retention. L monotherapy normalized albuminuria and prevented hypertension and the progression of renal injury, inflammation, and myofibroblast infiltration. In contrast to the remnant model, the LH combination promoted only slight additional renoprotection, perhaps because of a limited tendency to retain sodium in L Lact rats. angiotensin II; AT1 receptor; thiazides; chronic kidney disease ADMINISTRATION OF AT 1 RECEPTOR blockers or angiotensin-converting enzyme inhibitors during late murine nephrogenesis impairs renal vascular branching, as well as the interactions between the metanephric mesenchyme and the ureteral bud, resulting in severe hypotrophy of a substantial number of glomeruli and an overall reduction of 30% in the number of nephrons after weaning. In adult life, these animals develop glomerular and systemic hypertension; progressive albuminuria and glomerulosclerosis (GS); severe cortical interstitial inflammation; and renal insufficiency (7, 15, 16, 25) . Additional abnormalities are impaired urine concentrating ability and a trend to urinary salt wasting, possibly related to decreased expression of bumetanide-sensitive Na-K-2Cl cotransporters in Henle's loop (7, 15, 16) . Taking (16), the events conducing to the exuberant tubulointerstitial inflammation observed in this model remain obscure and might involve epithelial-to-mesenchymal transition, tissue hypoxia, and impaired degradation of extracellular matrix (ECM), among several other abnormalities. Moreover, attempts at detaining or retarding CKD progression in the L Lact model have not been performed, which leaves unanswered the question as to whether the severe nephropathy associated with this model is amenable to treatment.
inflammation; and renal insufficiency (7, 15, 16, 25) . Additional abnormalities are impaired urine concentrating ability and a trend to urinary salt wasting, possibly related to decreased expression of bumetanide-sensitive Na-K-2Cl cotransporters in Henle's loop (7, 15, 16) . Taking advantage of this adverse effect, we have recently standardized a new model of chronic kidney disease (CKD) based on the administration of the AT 1 receptor blocker losartan (L), during the final stage of nephrogenesis, which in rodents occurs during lactation (16) : the L Lact model.
Studies on the L Lact model are still scarce, leaving open several important aspects. First, the mechanisms that underlie the development of CKD in this model have not been completely elucidated. Although glomerular hypertrophy, glomerular hypertension, and podocyte injury may play a crucial role in the pathogenesis of GS (16) , the events conducing to the exuberant tubulointerstitial inflammation observed in this model remain obscure and might involve epithelial-to-mesenchymal transition, tissue hypoxia, and impaired degradation of extracellular matrix (ECM), among several other abnormalities. Moreover, attempts at detaining or retarding CKD progression in the L Lact model have not been performed, which leaves unanswered the question as to whether the severe nephropathy associated with this model is amenable to treatment.
Although several innovative therapeutic measures have been recently proposed for the treatment of CKD, renin-angiotensin system (RAS) suppression remains the best available resource in this regard, especially when accompanied by a diuretic (5, 26) . We recently demonstrated the association of L and hydrochlorothiazide (H) to be extremely efficient in reversing systemic hypertension and albuminuria (urinary albumin excretion rate; U alb V) and arresting the progression of CKD in the 5/6 renal ablation model, even when this combined therapy was started after GS and interstitial expansion (%INT) were already established (4) .
The aims of the present study were to further characterize the pathogenic mechanisms involved in the nephropathy associated with the L Lact model and to determine whether the extremely efficient renoprotection observed with the therapeutic LH association in 5/6 renal ablation rats can also be obtained in the L Lact model.
MATERIALS AND METHODS
Experimental protocol. Twenty-five adult female Munich-Wistar rats, aged from 10 to 12 wk and weighing 160 -200 g, obtained from a local facility at the University of São Paulo, were housed in individual plastic boxes after mating, receiving a regular rodent chow containing 0.5 Na and 22% protein (Nuvital Labs, Curitiba, Brazil), and tap water. Rats were maintained at 23 Ϯ 1°C and 60 Ϯ 5% relative air humidity, under an artificial 12:12-h light-dark cycle.
After delivery, six pups were kept with each dam until weaning. During the first 20 postnatal days, the dams received the AT 1 receptor antagonist L (250 mg·kg Ϫ1 ·day Ϫ1 ) dissolved in the drinking water. Twenty-five days after birth, pups were weaned and the male offspring that had been submitted to L treatment during lactation (L Lact) were kept untreated and allowed unrestrained access to food and tap water until 7 mo of age. All animals had their body weight (BW) measured weekly, and the tail-cuff pressure, as well as U albV, were determined every 3 mo. All experimental procedures were approved by the local Research Ethics Committee (CAPPesq, process no. 1117/06) and developed in strict conformity with our institutional guidelines and with international standards for manipulation and care of laboratory animals.
At 7 mo of age, L Lact rats, which already exhibited advanced renal injury, were divided among five groups: LLactPre (n ϭ 17), used as pretreatment control and followed no further; LLactϩV (n ϭ 15), kept untreated; LLactϩL (n ϭ 19), receiving L, 50 mg·kg Ϫ1 ·day Ϫ1 , now intended as a therapeutic agent; LLactϩH (n ϭ 17), receiving H, 6 mg·kg Ϫ1 ·day Ϫ1 ; and LLactϩLH (n ϭ 16), treated with both drugs. Animals were followed until 10 mo of age. Body weight (BW) measurements were performed weekly and tail-cuff pressure, as well as U albV, were determined monthly. Age-matched rats that have never received L during lactation were used as controls (n ϭ 19).
At the end of the observation period (7 mo for L LactPre and 10 mo for all other groups), the rats were anesthetized through an intraperitoneal injection of ketamine (50 mg/kg). Blood samples were drawn from the abdominal aorta for measurement of the concentrations of creatinine (serum), as well as sodium and potassium (plasma). The right kidney was excised and rapidly frozen at Ϫ70°C for subsequent assessment of matrix metalloproteinase (MMP) activity. The left kidney was retrogradely perfused in situ with Duboscq-Brazil solution at the measured arterial pressure, after a brief washout with saline to remove blood from renal vessels. After perfusion-fixation, the kidney was weighed and two midcoronal slices were postfixed in buffered 10% formaldehyde solution. The renal tissue was then embedded in paraffin by standard sequential techniques for assessment of glomerular and interstitial injury, as well as for immunohistochemical analysis.
Analytic techniques. U albV was determined by radial immunodiffusion (17) . Serum creatinine (Screat) concentration was assessed by a commercial colorimetric assay kit (Labtest, Minas Gerais, Brazil), based on the Jaffé alkaline picrate reaction. Sodium and potassium plasma concentrations were determined with ion-selective electrodes. Plasma and urine osmolality were measured by freezing-point osmometry.
Histomorphometric and immunohistochemical analysis. For assessment of the extent of glomerular injury, 4-m-thick sections from each rat were stained by the periodic acid-Schiff reaction. Glomerular damage was estimated by attributing to each glomerulus a score corresponding to the sclerosed fraction of the tuft area, and deriving a glomerulosclerosis index (GSI) for each animal as previously described (4) . At least 120 glomeruli were examined per rat. The percentage of the renal cortical area occupied by interstitial tissue, used as a measure of %INT, was estimated in Massonstained sections by a point-counting technique (10) .
Immunohistochemical analyses were performed to detect interstitial macrophage and lymphocyte infiltration, the presence of proliferating cell nuclear antigen (PCNA), the percentage of cortical interstitial area occupied by ␣-smooth muscle actin (%␣-SMA), and to evaluate the density of endothelial cells in the renal cortex. The following antibodies were employed in these assays: monoclonal mouse anti-rat ED-1 (Serotec, Oxford, UK), to identify rat macrophages, monoclonal mouse anti-CD3 antibody (Dako), to detect mature T lymphocytes, monoclonal mouse anti-PCNA (Dako), monoclonal mouse anti-␣-SMA (Sigma, St. Louis, MO), and JG12 monoclonal mouse anti-rat endothelial aminopeptidase P (Bender MedSystems). Details of the procedures adopted for immunohistochemistry are given elsewhere (4). The renal density of macrophages, lymphocytes, and proliferating cells was evaluated in a blinded http://ajprenal.physiology.org/ manner at ϫ200 magnification. For each section, 25 microscopic fields (corresponding to a total area of 1.6 mm 2 ) were examined. The percentage of renal cortical interstitial area occupied by ␣-SMA was estimated by the same point-counting technique employed to evaluate %INT, excluding positively stained blood vessels. The density of glomerular capillary endothelial cells was expressed as the percentage of glomerular area staining positively for endothelial aminopeptidase P, with the aid of image-processing software (Image Pro Plus, version 7.01). Peritubular capillaries were counted in each section, under ϫ200 magnification and expressed as the number of capillary profiles/ mm 2 of cortical interstitial tissue.
Gelatinolytic activity of MMP-2 and MMP-9.
We studied the activity of the main ECM gelatinases MMP-2 (ϳ71 kDa) and MMP-9 (ϳ92 kDa). Gelatinolytic activity was determined by a zymographic technique, following standardized procedures (12) . Negative bands obtained by gelatin degradation were evaluated with the aid of Image J software. Results obtained in experimental groups were factored by those obtained in age-matched controls.
Statistical analysis. Statistical differences were assessed by oneway ANOVA with pairwise posttest comparisons according to the Tukey method (27) . Differences were significant when P Ͻ 0.05. All calculations were performed using the GraphPad Prism 4.0 software, and results are expressed as means Ϯ SE. Pearson's correlation coefficient was used for linear regression analysis.
RESULTS
Long-term studies. Renal functional and systemic parameters obtained at the end of the study period are represented in Table 1 . BW and food intake did not differ significantly among groups. Mortality was numerically higher in untreated L Lact ϩV rats compared with the control group and numerically decreased by treatments. However, no significant difference in mortality was observed among groups.
Urine flow was markedly elevated in L Lact rats at 10 mo of age, attaining a mean value over twice as high as in agematched controls. Accordingly, urine osmolality was almost 30% lower than control in L Lact Pre animals and further reduced at 10 mo of age. At this time, untreated L Lact rats exhibited elevated S creat , reflecting the progression of CKD. None of the treatments prevented the rise of S creat that took place between 7 and 10 mo of age.
Corroborating previous studies, L Lact rats exhibited significant hypertension at 10 mo of age (Fig. 1) , and progressive albuminuria (U alb V) which reached values fivefold higher than control (Fig. 2) . Both L and H monotherapies partially prevented the progression of hypertension and albuminuria; how- Fig. 2 . Line graph representation of serial determinations of urine albumin excretion rate (UalbV). Open and filled symbols, superscript letters, and numbers of rats per group are defined as in Fig. 1 . ever, the LϩH association represented the best therapeutic strategy regarding these parameters.
Renal histomorphometric and immunohistochemical analysis. The analysis of renal structural damage is detailed in Figs. 3 and 4 . As expected, L Lact animals exhibited a significant increase in the GSI at 10 mo of age. Additionally, these rats presented a significant increase in the interstitial area at 7 mo of age, which reached values 10-fold higher than control at 10 mo of age. Both L monotherapy and the LϩH association prevented the aggravation of GS (Figs: 3A and 4A) but failed to detain interstitial expansion ( Figs: 3B and 4B) .
Prominent cortical interstitial macrophage and lymphocyte infiltration, as well as enhanced tubular and interstitial cell proliferation and ␣-SMA interstitial accumulation, were observed in 10-mo-old L Lact rats. (Figs. 5 and 6 ). Treatments had no effect on macrophage or lymphocyte infiltration. However, LϩH therapy prevented the progression of ␣-SMA accumulation and tubulointerstitial cell proliferation (Figs. 5-7) . Moreover, the analysis of aminopeptidase P showed no significant differences regarding either peritubular or glomerular endothelial cell density among groups (Figs. 8 and 9 ). However, a significant negative correlation between the density of peritubular capillaries and the INT% was observed at 10 ( Fig. 10B) , but not at 7 mo of age (Fig. 10A) .
MMP activity. L Lact animals exhibited a threefold increase in the activity of MMP-2 and a numerical increase in the activity of MMP-9 at 10 mo of age. Treatments exerted no effects on MMP activity (Fig. 11) .
DISCUSSION
Corroborating previous observations (7, 25) , hypertension was a late phenomenon in L Lact rats, although glomerular and interstitial injury was already evident in the L Lact rats at 7 mo of age. In prior studies, mild but distinctive glomerular and tubulointerstitial damage were observed even earlier, at 3 mo of age (7, 15, 16) . Together, these findings suggest that blood pressure rises in this model only when renal parenchymal injury and nephron loss reach a high grade of severity. One possible explanation for this behavior is the fact that the nephropathy associated with neonatal inhibition of the RAS is associated with much less tendency to retain sodium than observed for instance in the remnant model (7, 15) , due to an association of tubulointerstitial inflammation and impaired expression of sodium transporters (15) . This characteristic may postpone the development of hypertension until the number of nephrons falls to critical levels, thus limiting sodium excretion.
Progressive albuminuria and GS were also prominent features of L Lact rats, although less exuberant than in the remnant kidney model. The mechanisms underlying albuminuria and glomerular injury in this model have not been thoroughly elucidated and may involve podocyte damage (16), conceivably resulting from capillary hypertension and tuft hypertrophy associated with nephron number reduction, although intrinsic tubular abnormalities resulting directly from neonatal L treatment or acquired in adult life cannot be excluded (6, 21, 22) . L Lact animals exhibited pronounced cortical interstitial expansion at 7 mo of age, which was markedly aggravated 3 mo later. This abnormality was accompanied by exuberant interstitial macrophage and lymphocyte infiltration, along with prominent cell proliferative activity. These findings indicate the persistence, even at this advanced stage, of an active and self-sustained inflammatory process, whose origins are unclear. Glomerular injury may have propagated to the interstitial area through the formation of synechiae, known to be associated with GS in this and in other models (13) . Neonatal L treatment may have caused additional tubulointerstitial atrophy and interstitial inflammation by compromising the development of ureteral smooth muscle cells (18) , giving rise to reduced ureteral peristalsis, increased ureteral hydraulic pressure, and hydronephrosis. The interstitial inflammation associated with the L Lact model may also have been contributed by damage to the glomerular barrier and the ensuing albuminuria, stimulating the synthesis of inflammatory mediators by proximal tubular cells (1), although treatments used in this study reduced albuminuria without preventing the progression of interstitial expansion (see below).
Of particular interest was the intense staining for ␣-SMA observed in L Lact rats at 10 mo of age, especially at inflamed cortical interstitial areas, strongly suggesting the presence of myofibroblasts. The origin of these inflammatory cells in CKD is controversial. Myofibroblasts can stem directly from resident fibroblasts or be generated by conversion of tubular epithelial cells (epithelial-to-mesenchymal transition). The latter possibility is consistent with, although not proven by, the finding that a substantial fraction of the PCNA-positive cells detected in L Lact animals was associated with the tubular compartment. Whatever their origin, the occurrence of a large amount of myofibroblasts in renal parenchyma is known to stimulate the synthesis of both ECM components and of a variety of proinflammatory cytokines and chemokines, thus contributing to the establishment and perpetuation of an inflammatory environment (2, 14, 20, 23) .
The possible role of hypoxia in the pathogenesis of CKD has been extensively examined in recent years (9, 24) . In principle, the vascular malformation caused by neonatal L treatment could result in capillary rarefaction and hypoxia, thus contributing to the subsequent development of chronic renal inflammation and fibrosis. However, immunohistochemical analysis of endothelium-specific aminopeptidase P showed similar capillary density at both the glomerular and interstitial level in control and L Lact rats, suggesting that capillary rarefaction is not an important factor in the pathogenesis of renal injury in this model. The finding that the percent cortical interstitial area did not correlate with capillary density at 7 mo of age seems to corroborate this view. These findings are in disagreement with those obtained in other CKD models, in which capillary rarefaction and the resulting hypoxia are thought to play a major pathogenic role (3, 11, 19) . The reasons for this discrepancy are unclear. It must be noted that, whatever their nature, the mechanisms of renal injury in this model must start operating very early in life and, since they involve vascular malformation, it may be speculated that they could trigger compensatory mecha- Fig. 7 . Bar graph representation of immunohistochemistry for PCNA. Numbers of rats and superscript letters are as defined in Fig. 4 . nisms that might interfere with capillary density. On the other hand, a significant inverse correlation between percent cortical interstitial area and capillary density was observed in untreated L Lact rats at 10 mo of age, suggesting that capillary rarefaction and hypoxia may play a role at more advanced phases of the disease. Additional studies are necessary to establish whether severe interstitial fibrosis and capillary distortion hamper oxygen diffusion in this model, promoting cell hypoxia even in the absence of overt capillary rarefaction (3, 19) .
An additional hypothesis for the marked interstitial accumulation of fibrous material observed in L Lact rats is that lack of ANG II activity during nephrogenesis may have impaired degradation of the ECM (8) and that this condition may have persisted through adult life. Our results are inconsistent with this hypothesis, however, since the activities of both MMP-2 and MMP-9 were increased, rather than decreased, in L Lact rats, suggesting that impaired proteolysis is not the explanation for the prominent matrix accumulation observed in this group.
The present study represents the first attempt at treating the CKD caused by suppression of RAS activity during lactation. Interestingly, L, the very drug that promotes chronic nephropathy when given during lactation, prevented hypertension and albuminuria and limited the progression of GS, when administered to the same animals in adult life. Thus L exerted similar protection of glomerular structure in L Lact nephropathy as in other instances of CKD.
We showed previously that the L Lact model is characterized by elevated glomerular pressure at earlier stages (16) . Although the profound distortion of the renal surface at more advanced phases precludes direct examination of glomerular hemodynamics, it is conceivable that the glomerular structural protection obtained with L resulted from attenuation or reversal of glomerular hypertension, such as observed in other CKD models (4). L monotherapy did not prevent the progression of interstitial expansion, proliferation, interstitial inflammation, or ␣-SMA accumulation in the L Lact rats. Although the beneficial action of L monotherapy in other models has been associated with the limitation of interstitial infiltration by lymphocytes and macrophages (4), such an effect was not observed in this study.
In disagreement with the established view that thiazides are ineffective in advanced CKD, H monotherapy prevented the rising of both blood pressure and albuminuria in the L Lact rats, indicating that some response to diuretics was preserved in this model despite the lower tendency to retain sodium associated with it. However, a significant protective effect of H monotherapy was not seen regarding interstitial expansion, leukocyte infiltration, ␣-SMA accumulation, or interstitial cell proliferation.
Combined LϩH treatment lowered systolic blood pressure of the L Lact ϩLH group below pretreatment levels. The association also normalized albuminuria, suggesting a synergistic interaction between H and L, probably stemming from their differing, complementary hemodynamic effects. Nevertheless, the same synergistic interaction was not observed regarding S creat retention and renal structural injury. Moreover, the association of H with L treatment promoted no additional improvement of GS or interstitial expansion. These results differ from those obtained in the 5/6 renal ablation model, in which the LϩH association not only promoted normalization of both albuminuria and blood pressure but also completely arrested glomerular and interstitial injury, as well as renal inflammation (4). The reasons for this discrepancy are unclear. At 10 mo of age, the complex process of fibrosis set off by neonatal L treatment may have reached a stage in which production of ever increasing amounts of ECM responds little to any therapeutic measure, and the limited protection obtained with L monotherapy can hardly be improved. It is conceivable that treatments initiated earlier, at a time when renal injury is still relatively mild and hypertension is still absent, would be more effective than observed in the present study. On the other hand, it should be noted that, as shown previously (7, 25) , rats subjected to RAS inhibition during nephrogenesis show less tendency to retain sodium than in other CKD models, due to an association of tubulointerstitial inflammation and impaired expression of sodium transporters (15) , to such an extent that, as pointed out earlier, only after 7 mo of age does relatively moderate hypertension develop (16) . Thus the typical sodium-wasting and hemodynamic effect of diuretics may be relatively limited in this model. By contrast, the 5/6 renal ablation model, at least when obtained by ligation of branches of the renal artery, is characterized by early development of glomerular and systemic hypertension associated with intense renal inflammation, all of which respond exquisitely to diuretic therapy, especially when combined with suppressors of the RAS (4) .
Although the LH treatment exerted no effect on the renal macrophage and lymphocyte infiltration observed in L Lact rats, it prevented the renal interstitial accumulation of ␣-SMA in this model. The reasons for this interesting dissociation, which was previously demonstrated in other CKD models (28) , are unclear. However, it should be noted that combined treatment also reduced interstitial and tubular cell proliferation, which may have reduced myofibroblast accumulation by limiting its two main sources, proliferation of stromal fibroblasts or epithelial-to-mesenchymal transdifferentiation.
In summary, the L Lact model mimics several important aspects of advanced human CKD. Continuing interstitial infiltration by macrophages, lymphocytes, and myofibroblasts, as well as enhanced tubular and interstitial cell proliferation, are prominent features of this model and help to explain the progressive and aggressive interstitial expansion associated with it. Treatment with L reversed hypertension and albuminuria and prevented progression of renal injury and inflammation. Adding H enhanced only slightly the renoprotective effect of L, in contrast to the 5/6 renal ablation model, in which the LϩH association exerts a much more efficacious renoprotective effect. This discrepancy may relate to the limited tendency to retain sodium known to be associated with this new model.
